What's New on the FDA Drugs Site
July 17, 2013
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drugs@FDA Data Files (updated)
- National Drug Code Directory
New and Generic Drug Approvals
July 16, 2013
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Acamprosate Calcium | acamprosate calcium | Tablet, Delayed Release; Oral | Glenmark Generics | Approval |
| Eliquis | apixaban | Tablet; Oral | Bristol Myers Squibb | Manufacturing Change or Addition |
| Eloxatin | oxaliplatin | Injectable; Iv (Infusion) | Sanofi Aventis Us | Labeling Revision |
| Elspar | asparaginase | Vial | Merck | Labeling Revision |
| This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
No comments:
Post a Comment